A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox (HA22, CAT-8015): Activity in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT)

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox (HA22, CAT-8015): Activity in Pediatric Patients with Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplantation (SCT)

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation Vol. 18; no. 2; p. S234
Main Authors: Shah, N.N, Bhojwani, D, Silverman, L.B, Whitlock, J.A, Richards, K, Stetler-Stevenson, M, Buzoianu, M, Ibrahim, R, Pastan, I, Wayne, A.S
Format: Journal Article
Language:English
Published: Elsevier Inc 2012
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2011.12.091